黛力新治疗慢性阻塞性肺疾病加重期焦虑抑郁症

目的：探讨抗焦虑抑郁药物黛力新在对慢性阻塞性肺疾病加重期焦虑抑郁患者中的疗效。方法：对于符合慢性阻塞性肺疾病加重期标准患者,采用汉密尔顿焦虑量表（HAMA）测量心理状况,将患者分为黛力新组及对照组,治疗2周后再检测患者的各项观察指标。结果：治疗2周后两组对比,黛力新组HAMA得分均有降（P〈0.01）,COPD加重期各项疗效指标均有明显改善,显效率100%（P〈0.01）。结论：黛力新能改善慢性阻塞性肺疾病加重期患者的焦虑及抑郁症状。

Application of Deanxit of Anxiety and Depression in COPD with Exacerbation

Objective：To investigate the anti-anxiety drugs deanxit depression on COPD exacerbations of efficacy in patients with anxiety and depression.Methods：For those patients with COPD exacerbation criteria,using the Hamilton Anxiety Scale （HAMA） measure of psychological status,patients were divided into deanxit group and control group,treatment of patients with 2W after detection of the observation target.Results：The treatment groups after 2W contrast deanxit Group HAMA scores were lower （P0.01）,COPD exacerbation of the efficacy parameters were significantly improved,markedly effective rate 100% （P0.01）.Conclusions：deanxit can improve COPD patients with exacerbation of symptoms of anxiety and depression.